214 related articles for article (PubMed ID: 7554326)
21. Action of EDTA-Tris and antimicrobial agent combinations on selected pathogenic bacteria.
Wooley RE; Jones MS
Vet Microbiol; 1983 Jun; 8(3):271-80. PubMed ID: 6412426
[TBL] [Abstract][Full Text] [Related]
22. Otitis externa: management of the recalcitrant case.
Selesnick SH
Am J Otol; 1994 May; 15(3):408-12. PubMed ID: 8579150
[TBL] [Abstract][Full Text] [Related]
23. Discovery of novel pyridinopolyamines with potent antimicrobial activity: deconvolution of mixtures synthesized by solution-phase combinatorial chemistry.
An H; Haly BD; Cook PD
J Med Chem; 1998 Feb; 41(5):706-16. PubMed ID: 9513599
[TBL] [Abstract][Full Text] [Related]
24. Microbial aetiology of otitis externa.
Dibb WL
J Infect; 1991 May; 22(3):233-9. PubMed ID: 1906504
[TBL] [Abstract][Full Text] [Related]
25. [Otomycosis: a microbiological study of 147 cases of otitis externa].
Sagnelli M; Cristalli G; Bruno E; Marzullo C; Abramo A; Pollastrini L
An Otorrinolaringol Ibero Am; 1993; 20(5):521-30. PubMed ID: 8291668
[TBL] [Abstract][Full Text] [Related]
26. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
Cantrell HF; Lombardy EE; Duncanson FP; Katz E; Barone JS
South Med J; 2004 May; 97(5):465-71. PubMed ID: 15180022
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of bupivacaine and pethidine.
Grimmond TR; Brownridge P
Anaesth Intensive Care; 1986 Nov; 14(4):418-20. PubMed ID: 3105346
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity and spectrum of bacterial isolates in infectious otitis externa.
Mahmood A
J Coll Physicians Surg Pak; 2004 Sep; 14(9):580-1; author reply 581. PubMed ID: 15353150
[No Abstract] [Full Text] [Related]
29. Malignant Otitis Externa: Evolving Pathogens and Implications for Diagnosis and Treatment.
Hobson CE; Moy JD; Byers KE; Raz Y; Hirsch BE; McCall AA
Otolaryngol Head Neck Surg; 2014 Jul; 151(1):112-6. PubMed ID: 24675790
[TBL] [Abstract][Full Text] [Related]
30. Comparison of microbial isolates and susceptibility patterns from the external ear canal of dogs with otitis externa.
Graham-Mize CA; Rosser EJ
J Am Anim Hosp Assoc; 2004; 40(2):102-8. PubMed ID: 15007044
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antimicrobial activity of α-aminoboronic-containing peptidomimetics.
Gozhina OV; Svendsen JS; Lejon T
J Pept Sci; 2014 Jan; 20(1):20-4. PubMed ID: 24222512
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial effect of combinations of EDTA-Tris and amikacin or neomycin on the microorganisms associated with otitis externa in dogs.
Sparks TA; Kemp DT; Wooley RE; Gibbs PS
Vet Res Commun; 1994; 18(4):241-9. PubMed ID: 7831753
[TBL] [Abstract][Full Text] [Related]
33. Screening of some Cuban medicinal plants for antimicrobial activity.
Martínez MJ; Betancourt J; Alonso-González N; Jauregui A
J Ethnopharmacol; 1996 Jul; 52(3):171-4. PubMed ID: 8771459
[TBL] [Abstract][Full Text] [Related]
34. [Malignant otitis externa caused by Candida albicans].
Elayoubi F; Lachkar A; Aabach A; Chouai M; Ghailan MR
Pan Afr Med J; 2016; 24():322. PubMed ID: 28154677
[TBL] [Abstract][Full Text] [Related]
35. The antibacterial activity of acetic acid and Burow's solution as topical otological preparations.
Thorp MA; Kruger J; Oliver S; Nilssen EL; Prescott CA
J Laryngol Otol; 1998 Oct; 112(10):925-8. PubMed ID: 10211213
[TBL] [Abstract][Full Text] [Related]
36. In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa.
Chan WY; Hickey EE; Khazandi M; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2018 Apr; 29(2):149-e57. PubMed ID: 29363210
[TBL] [Abstract][Full Text] [Related]
37. Malignant otitis externa in AIDS patients: case report and review of the literature.
Weinroth SE; Schessel D; Tuazon CU
Ear Nose Throat J; 1994 Oct; 73(10):772-4, 777-8. PubMed ID: 7805599
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the Antimicrobial Activity of Algae Extracts on Bacteria Responsible of External Otitis.
Pane G; Cacciola G; Giacco E; Mariottini GL; Coppo E
Mar Drugs; 2015 Oct; 13(10):6440-52. PubMed ID: 26492256
[TBL] [Abstract][Full Text] [Related]
39. Microbial inhibition on hospital garments treated with Dow Corning 5700 antimicrobial agent.
Murray PR; Niles AC; Heeren RL
J Clin Microbiol; 1988 Sep; 26(9):1884-6. PubMed ID: 3141471
[TBL] [Abstract][Full Text] [Related]
40. [Antibiotic treatment of Pseudomonas aeruginosa-induced ear canal disease].
Federspil P
Laryngorhinootologie; 1993 Mar; 72(3):158. PubMed ID: 8471101
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
